A statement containing a finding that a release of hazardous substances poses a significant risk to human health recommending measures to be taken to ↓ exposure and eliminate or substantially mitigate the risk to human health
The FDA previously informed the public about the possibility of serious neuropsychiatric symptoms with varenicline in November 2007, and later issued a public health advisory in February 2008 about new warnings and precautions in the drug's labeling about the risk of such symptoms.
The Food and Drug Administration has released a public health advisory strongly recommending against the use of over-the-counter cough and cold products in children and infants aged under 2 years, but will not issue recommendations until the spring about the use of these products in children aged 2-11 years.
In 2004 the Public Health Advisory Committee (PHAC), a sub-committee of the National Health Committee, published A Guide to Health Impact Assessment: A Policy Tool for New Zealand (Public Health Advisory Committee 2004) to facilitate policy-level HIA in New Zealand.
The FDA's black-box warning is aimed at children and adolescents, but this past July the FDA issued a public health advisory on the use of antidepressants by adults, recommending they be "watched closely for worsening of depression and for increased suicidal thinking or behavior," and that adults whose symptoms worsen while on antidepressants should be evaluated by their healthcare professional.